The Securities and Exchange Commission has not necessarily
reviewed the information in this filing and has not determined
if it is accurate and complete.
| |||||||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ABIVAX SA | SPONSORED ADS | 00370M103 | 348,215,205 | 3,621,583 | SH | SOLE | 3,621,583 | 0 | 0 | ||
| BELITE BIO INC | SPONSORED ADS | 07782B104 | 456,588,244 | 3,077,219 | SH | SOLE | 3,077,219 | 0 | 0 | ||
| INSMED INC | COM PAR $.01 | 457669307 | 673,600,013 | 6,431,163 | SH | SOLE | 6,431,163 | 0 | 0 | ||
| REVOLUTION MEDICINES INC | COM | 76155X100 | 2,047,516,314 | 10,629,822 | SH | SOLE | 10,629,822 | 0 | 0 | ||
| ROIVANT SCIENCES LTD | SHS | G76279101 | 234,333,729 | 6,747,300 | SH | SOLE | 6,747,300 | 0 | 0 | ||